Mobile application for assessing the likelihood of developing depression in patients with Parkinson’s disease
Objective: To develop a mobile application for assessing the likelihood of developing depression in patients with Parkinson's disease (PwPD), taking into account the number of…Are we addressing the emotional burden? – recognition of mood disorders in patients with essential tremor
Objective: To examine the assessment of non-motor symptoms in essential tremor in movement disorder clinics. Background: Essential tremor (ET) is one of the most common…Analysis of the correlation between the raphe nucleus echo and neurological diseases with depression/anxiety.
Objective: The objective of this study is to assess raphe nucleus echo whether can be used as a means to distinguish endogenous and reactive depression/anxiety, so as to…Self perceived impact of the SARS-COV 2 pandemic on motor, non motor and affective symptoms in Parkinson’s disease and parkinsonisms.
Objective: to evaluate the perceived impact of the SARS-COV 2 pandemic on own wellbeing in people with Parkinson’s disease and parkinsonism (PWP) in Italy. Background:…GALLIC ACID AMELIORATES THE NEUROBEHAVIOURAL DEFICITS INDUCED BY BISPHENOL A (BPA) IN WISTAR RATS
Objective: Bisphenol A (BPA) has been found to exert neurotoxic effects through its neuroendocrine disruption and generation of reactive oxygen species (ROS). It can also…Cognitive complaints, anxiety, depression and reporting of pain in Parkinson’s Disease in a multi-ethnic population: Dissimilarities between White and Non-White patients
Objective: To explore the links between cognitive complaints, anxiety and depression and reporting of pain in People with Parkinson’s disease (PD, PwP) from different ethnic…Impact of extended quarantine during the COVID-19 pandemic on Parkinson’s disease (PD) patients.
Objective: To determine the impact of extended quarantine during the COVID-19 pandemic in PD patients. Background: Due to the Covid-19 pandemic, various types of social…Predictors of Clinically Significant Quality of Life Impairment in Parkinson´s Disease. Results from the COPPADIS Cohort at 2 Years Follow-up.
Objective: The aim of the present study was to identify predictors of clinically significant quality of life (QoL) impairment in Parkinson´s disease (PD) patients from…Effects of safinamide adjunct therapy on non-motor symptoms in patients with Parkinson’s disease: a post-hoc analysis of the Japanese Phase 2/3 study
Objective: To evaluate the efficacy of safinamide for mood and pain by a post-hoc analysis of the Japanese phase 2/3 double-blind study (JapicCTI-153056) in patients…Mood is a Key Factor in Progression of Non-Motor Symptoms Burden in Parkinson´s disease.
Objective: The aim of the present study was to identify predictors of non-motor symptoms burden non-progression (NMSB-NP) in PD patients from a Spanish cohort [1,2].…
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- …
- 38
- Next Page »